GGrantIndex
Sort

78,016 grants matching breast cancer

Discovery and characterization of clinically actionable germline mutations in DNA damage repair (DDR) pathway genes in lung cancer

$676,729
Semanti Mukherjee · Sloan-Kettering Inst Can Research · R37 · FY2024 · CA

SAN FRANCISCO MAMMOGRAPHY REGISTRY--A RESEARCH RESOURCE

$676,720
University Of California San Francisco · U01 · FY2002 · CA

Clinical Protocol and Data Management (Core 018)

$676,693
Elizabeth C Dees · Univ Of North Carolina Chapel Hill · P30 · FY2017 · CA

CHARGE consortium: gene discovery for CVD and aging phenotypes

$676,646
Bruce M Psaty · University Of Washington · R01 · FY2020 · HL

Decoding the co-evolution of cancer subclones and their ecosystem in TNBC multi-organ metastasis

$676,584
Nicholas Navin · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA

Systematic Testing of a TGFβ Targeted Theranostic in Preclinical Cancer

$676,567
Mary Helen Barcellos-Hoff · University Of California, San Francisco · R01 · FY2025 · CA

Leadership, Planning, and Evaluation

$676,378
Stanton L Gerson · Case Western Reserve University · P30 · FY2019 · CA

Postmenopausal Monkey Resource

$676,321
Cynthia Louise Bethea · Oregon Health & Science University · R24 · FY2015 · OD

Cancer Screening Behavior in Hispanic/Latinas Living in the Northeast United Stat

$676,276
Beth A Jones · Yale University · R01 · FY2010 · CA

JAK-STAT Inhibition to Reduce Racial Disparities in Kidney Disease

$676,165
Opeyemi Ayodeji Olabisi · Duke University · R01 · FY2021 · MD

Synthetic lethal targeting of EBV-positive diffuse large B cell lymphomas in persons living with HIV

$676,145
Sumita Bhaduri-McIntosh · University Of Florida · U01 · FY2025 · CA

Developing liquid biopsy tests for malignant effusions using artificial intelligence-assisted, morphology-based isolation of tumor cells

$676,075
Mark Jesus Magbanua · University Of California, San Francisco · R01 · FY2025 · CA

Precision Assessment and Delivery of Cancer Risks in BRCA 1/2 Mutation Cancers

$676,046
Timothy R Rebbeck · Dana-Farber Cancer Inst · R01 · FY2021 · CA

CCR FACS Core Laboratory

$675,994
Barbara Taylor · Division Of Basic Sciences - Nci · ZIC · FY2010 · CA

Label-Free Optical Redox Imaging for Pretreatment Prognosis of Early-Stage Triple Negative Breast Cancer

$675,960
Lin Z Li · University Of Pennsylvania · R01 · FY2023 · CA

Human Proteome Arrays for Auto-Antibody Identification in Clinical Cancer Studies

$675,834
John H Kenten · Meso Scale Diagnostics, Llc · R44 · FY2009 · CA

Quantifying and Characterizing the shared genetic contribution to common cancers

$675,732
Sara Lindstroem · Harvard School Of Public Health · U01 · FY2015 · CA

THE CONTRIBUTION OF RARE VARIANTS IN FAMILIAL CLUSTERING OF PROSTATE AND BREAST CANCER IN AFRICAN AMERICANS

$675,729
Wayne State University · · FY2017 · Department of the Army

Identification of Genes and DNA Methylation Markers for Lung Cancer Risk by Integrating Multi-omics Data

$675,718
Qiuyin Cai · Vanderbilt University Medical Center · R01 · FY2022 · CA

(PQC3) Ethnicity-determined immune response and DCIS outcome

$675,664
Sunil S. Badve · Indiana University Indianapolis · R01 · FY2017 · CA

Radiation-induced translational control of gene expression

$675,650
Philip Tofilon · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion

$675,590
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways

$675,590
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA

Clinical Pregnancy Outcomes in Adolescent and Young Adult Female Cancer Survivors

$675,579
Hazel B Nichols · Univ Of North Carolina Chapel Hill · R01 · FY2017 · CA

Adipocyte PD-L1 in the Breast Tumor Microenvironment

$675,405
Rong Li · George Washington University · R01 · FY2024 · CA